P&T committee means a committee of the hospital composed of physicians, pharmacists, and other health professionals that evaluates the clinical use of drugs within the hospital, develops policies for managing drug use and administration in the hospital, and manages the hospital drug formulary system. “Physician” means a person who is currently licensed in Iowa to practice medicine and surgery, osteopathic medicine and surgery, or osteopathy. A physician who executes a written protocol with an authorized pharmacist shall supervise the pharmacist’s activities involved in the overall management of patients receiving medications or disease management services under the protocol. The physician may
P&T committee means a committee of the hospital composed of physicians, pharmacists, and other health professionals that evaluates the clinical use of drugs within the hospital, develops policies for managing drug use and administration in the hospital, and manages the hospital drug formulary system. “Physician” means a person who is currently licensed in Iowa to practice medicine and surgery
P&T committee means a committee of the hospital composed of physicians, pharmacists, and other health professionals that evaluates the clinical use of drugs within the hospital, develops policies for managing drug use and administration in the hospital, and manages the hospital drug formulary system. “Therapeutic interchange” means an authorized exchange of therapeutic alternate drug products in
Examples of P&T committee in a sentence
A statement of the medication categories and the type of initiation and modification of drug therapy that the P&T committee authorizes the hospital pharmacist to perform.
The names or groups of pharmacists and physicians who are authorized by the P&T committee to participate in collaborative drug therapy management.
The names or groups of physicians and pharmacists who are authorized by the P&T committee to participate in collaborative drug therapy management.
The Plan Sponsor retains the authority to deny access to quantities or doses during transition (e.g., where clearly articulated safety limits established by the FDA or based upon the same peer reviewed medical literature or well-established clinical practice guidelines used by the Pharmacy & Therapeutics (P&T) committee in formulary management have been exceeded).
By including a psychiatrist on the clinical P&T committee, Cigna ensures that comparable clinical expertise in treating MH/SUD conditions and M/S conditions is represented in the formulary decision-making process.
More Definitions of P&T committee
P&T committee means the Pharmacy and Therapeutics Committee established by the Administrative Director pursuant to Labor Code section 5307.29 to review and consult with the administrative director on available evidence of the relative safety, efficacy, and effectiveness of drugs within a class of drugs in the updating of the evidence-based drug formulary.
P&T committee means that United HealthCare committee that: (i) reviews a prescription drug for inclusion on the United HealthCare Preferred Drug List or other comparable formularies; and, (ii) develops other criteria, procedures and rules for the Program including but not limited to quantity level and prior authorization.
P&T committee means the Pharmacy & Therapeutics Committee maintained by Medco,
P&T committee or "Committee" means this independent Pharmacy and Therapeutics Committee established by the 2003 Legislature at Section 9, SB 6088, amending RCW 70.14.050(4). The P&T Committee also serves as the Drug Utilization Review Board (DUR) established by the state of Washington Department of Social and Health Services, Medical Assistance Administration (DSHS/MAA), as set forth in WAC 388-530-1850 and the federal Social Security Act, Title 19 §1927.
P&T committee means a committee comprised of both voting and non-voting Cigna-employed clinicians, Medical Directors and Pharmacy Directors and non-Employees such as Participating Providers that represent a range of clinical specialties. The committee regularly reviews pharmaceutical products, new pharmaceutical products, for safety and efficacy, the findings of which clinical reviews inform coverage status decisions made by the Business Decision Team. The P&T Committee’s review may be based on consideration of, without limitation, FDA-approved labeling, standard medical reference compendia, or scientific studies published in peer-reviewed English-language bio-medical journals. ● "PBM Proprietary Information" shall mean information relating to CHLIC's pharmacy benefit management products and services, including, without limitation, CHLIC's reporting and web-based applications, eligibility and adjudication systems and coding methodologies, system formats and databanks, clinical or formulary management operations or programs, information and agreements relating to Rebates and other financial information, prescription drug evaluation criteria and coverage policies, drug pricing information, including MAC List and Specialty Drug pricing, paid Claims information integrated into CHLIC's adjudication systems, and pharmaceutical manufacturer, vendor or pharmacy network agreements. ● “Prescription Drug Charge” shall mean the amount that, prior to application of the Plan’s cost-share requirement(s), Employer is obligated to pay for a Covered Drug dispensed at a Retail Pharmacy or Cigna Home Delivery Pharmacy, including any applicable Dispensing Fee, service fee, and tax. The Prescription Drug Charge may be expressed as, for example, a discount off of AWP or other benchmark price, or a MAC.
P&T committee means the committee established pursuant to 42 USC 1396r-8 or Participating Medicaid Program enabling legislation, as applicable, for the purpose of consulting with the state agency or department responsible for administering the Participating Medicaid Program toward adoption of a Preferred Drug List for the Participating Medicaid Program.
P&T committee means Pharmacy and Therapeutics Committee.